Patients undergoing tirzepatide therapy commonly experience: Improved blood pressure: reductions in systolic and diastolic blood pressure have been observed across tirzepatide clinical trials Better cholesterol profiles: reductions in LDL and triglycerides, with improvements in HDL Improved blood glucose regulation: tirzepatide significantly improves insulin sensitivity and reduces fasting glucose, even in patients without diabetes Reduction in waist circumference: visceral fat reduction, which is directly associated with reduced cardiovascular and metabolic risk Preservation of lean muscle mass: unlike traditional caloric restriction, which often results in 2530% of weight loss coming from muscle, tirzepatide promotes preferential fat loss Potential hormonal benefits: emerging evidence suggests that fat mass reduction lowers aromatase activity, which may support healthier testosterone-to-estrogen balance For patients managing multiple metabolic conditions simultaneously, GLP-1/GIP weight loss therapy represents an opportunity to address root causes, rather than individual symptoms, through a single medically supervised intervention

Enhancing Blood Sugar Control: Incorporating semaglutide GLP-1 into our treatment protocols allows us to offer patients enhanced blood sugar regulation through its multifaceted mechanisms: Optimized Insulin Secretion: By stimulating insulin production in response to high blood sugar, semaglutide aids in effective glucose uptake, crucial for our diabetic patients
In: DeGroot LJ, Jameson JL, editors
Chest 129, 431437
So, I went ahead and I booked my appointment and I got to meet Tristan
Nutraceutical-grade oils typically contain 1000 mg/kg or higher, with some ultra-high polyphenol varieties exceeding 2,000 mg/kg